Fenamates as Potential Therapeutics for Neurodegenerative Disorders.

Fenamates as Potential Therapeutics for Neurodegenerative Disorders.
复制标题

DOI:
10.3390/cells10030702
复制
发表时间:
2021-03-22
期刊:
影响因子:
6
通讯作者:
Zawia NH
Zawia NH
中科院分区:
生物学2区
文献类型:
--
作者:
Hill J;Zawia NH

文献摘要

参考文献

被引文献

相似文献

神经退行性疾病极度缺乏治疗选择。在与神经退行性疾病的斗争中,必须考虑药物再利用。人们研究了雌胺类药物治疗几种神经退行性疾病的疗效。这篇综述的目的是全面介绍过去和现在的研究在神经退行性疾病的背景下,特别强调tolfenamic acid和阿尔茨海默病。此外,本文还讨论了雌性动物调节的主要分子途径。
Neurodegenerative disorders are desperately lacking treatment options. It is imperative that drug repurposing be considered in the fight against neurodegenerative diseases. Fenamates have been studied for efficacy in treating several neurodegenerative diseases. The purpose of this review is to comprehensively present the past and current research on fenamates in the context of neurodegenerative diseases with a special emphasis on tolfenamic acid and Alzheimer’s disease. Furthermore, this review discusses the major molecular pathways modulated by fenamates.
DOI: 10.1038/ncomms12504
发表时间: 2016-08-11
影响因子: 16.6
作者:
Daniels MJ;Rivers-Auty J;Schilling T;Spencer NG;Watremez W;Fasolino V;Booth SJ;White CS;Baldwin AG;Freeman S;Wong R;Latta C;Yu S;Jackson J;Fischer N;Koziel V;Pillot T;Bagnall J;Allan SM;Paszek P;Galea J;Harte MK;Eder C;Lawrence CB;Brough D
通讯作者: Brough D
DOI: 10.1186/s13024-015-0025-8
发表时间: 2015-07-14
影响因子: 15.1
作者:
Caillet-Boudin ML;Buée L;Sergeant N;Lefebvre B
通讯作者: Lefebvre B
DOI: 10.1186/s12929-018-0457-x
发表时间: 2018-07-10
影响因子: 11
作者:
Chang HY;Sang TK;Chiang AS
通讯作者: Chiang AS
DOI: 10.1002/alz.12068
发表时间: 2020-03-01
影响因子: 14
作者:
通讯作者: --
DOI: 10.1016/j.ygyno.2011.03.014
发表时间: 2011-07-01
影响因子: 4.7
作者:
Basha, Riyaz;Ingersoll, Susan B.;Abdelrahim, Maen
通讯作者: Abdelrahim, Maen